TSPAN14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.775600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.145640E-02
Normal-vs-Stage2
3.231900E-02
Normal-vs-Stage3
9.796200E-02
Normal-vs-Stage4
1.173160E-01
Stage1-vs-Stage2
1.387150E-01
Stage1-vs-Stage3
8.393200E-01
Stage1-vs-Stage4
7.406200E-01
Stage2-vs-Stage3
3.630600E-01
Stage2-vs-Stage4
4.725400E-01
Stage3-vs-Stage4
9.252000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.883700E-02
Normal-vs-AfricanAmerican
6.679600E-02
Normal-vs-Asian
1.416130E-02
Caucasian-vs-AfricanAmerican
8.308800E-01
Caucasian-vs-Asian
5.889600E-01
AfricanAmerican-vs-Asian
5.658000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.930010E-02
Normal-vs-Female
4.820300E-02
Male-vs-Female
4.639600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.277830E-01
Normal-vs-Age(41-60Yrs)
5.144500E-02
Normal-vs-Age(61-80Yrs)
2.716100E-02
Normal-vs-Age(81-100Yrs)
1.641090E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.077400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.974000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.485000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.281700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.903900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.849400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.461900E-02
Normal-vs-Daily Drinker
3.195700E-02
Normal-vs-Weekly Drinker
1.319440E-01
Normal-vs-Occasional Drinker
1.206000E-02
Normal-vs-Social Drinker
1.027600E-01
Non Drinker-vs-Daily Drinker
9.874800E-01
Non Drinker-vs-Weekly Drinker
4.931000E-01
Non Drinker-vs-Occasional Drinker
8.595000E-01
Non Drinker-vs-Social Drinker
3.391400E-01
Daily Drinker-vs-Weekly Drinker
5.201400E-01
Daily Drinker-vs-Occasional Drinker
8.805800E-01
Daily Drinker-vs-Social Drinker
3.689200E-01
Weekly Drinker-vs-Occasional Drinker
4.343000E-01
Weekly Drinker-vs-Social Drinker
8.666800E-01
Occasional Drinker-vs-Social Drinker
2.855800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.843400E-01
Normal-vs-Grade 2
3.082100E-02
Normal-vs-Grade 3
3.118000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.87490000000446E-05
Grade 1-vs-Grade 3
2.192500E-04
Grade 1-vs-Grade 4
4.843400E-01
Grade 2-vs-Grade 3
5.479400E-01
Grade 2-vs-Grade 4
3.082100E-02
Grade 3-vs-Grade 4
3.118000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.479800E-02
Normal-vs-NonDiabetic
2.921500E-02
Diabetic-vs-NonDiabetic
6.442400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.429820E-01
Normal-vs-NoPancreatitis
2.729700E-02
Pancreatitis-vs-NoPancreatitis
1.143160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.798110E-02
Normal-vs-N1
3.531700E-02
N0-vs-N1
5.070200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.886590E-01
Normal-vs-TP53-NonMutant
1.226480E-02
TP53-Mutant-vs-TP53-NonMutant
1.68908999998996E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
